The sole of a foot with a diabetic foot ulcer.

Diabetic Foot Ulcer (DFU) Solutions

Contact a representative

Research has shown that patients with diabetes have up to a 25% lifetime risk of diabetic foot ulceration (DFU), one of the most frequently recognized complications of diabetes.1 DFUs are the leading nontraumatic cause of lower extremity foot amputations worldwide.2


Cost of Diabetic Foot Ulcers

  • An icon of a person and three bank notes.

    An estimated $547 million is spent to treat DFUs in the Canadian healthcare system anually.1

  • An icon of a patient lying in a hospital bed with their food elevated.

    People with diabetes have a 15-25% lifetime risk of developing foot ulcers.2

  • An icon of a gar graph with an increasing trend.

    The prevalence of diabetes in Canada is expected to rise to 5 million by 2025.3


Four-step Solution to DFU Management

Key components of best practice wound management of the diabetic foot ulcer4 include treatment of underlying disease process, ensuring adequate blood supply, local wound care (including infection control), and pressure off-loading.


Step 1: Cleanse, Moisturize, and Protect

Cleanse
Moisturize
Protect
Cleanse
Moisturize

Step 2: Optimize Wound Environment

Manage Bioburden
Provide Collagen and ORC
  • A silver medical dressing.

    3M™ Silvercel™ Dressing Family

    Helps manage bacterial contamination and infection in moderate to highly exuding partial and full thickness wounds.

  • Two hexagonal PROMOGRAN™ PRISM™ Wound Balancing Matrix.

    3M™ Promogran™ Matrix Family and 3M™ Promogran Prisma™ Wound Balancing Matrix

    Helps manage elevated protease and elastase activity in a wound. In vitro studies have demonstrated that the combination of oxidized regenerated cellulose (ORC) and collagen materials has a greater effect in reducing both MMP and elastase activity than collagen alone.9,10

    Manage Bioburden
  • A silver medical dressing.

    3M™ Silvercel™ Dressing Family

    Helps manage bacterial contamination and infection in moderate to highly exuding partial and full thickness wounds.

  • Provide Collagen and ORC
  • Two hexagonal PROMOGRAN™ PRISM™ Wound Balancing Matrix.

    3M™ Promogran™ Matrix Family and 3M™ Promogran Prisma™ Wound Balancing Matrix

    Helps manage elevated protease and elastase activity in a wound. In vitro studies have demonstrated that the combination of oxidized regenerated cellulose (ORC) and collagen materials has a greater effect in reducing both MMP and elastase activity than collagen alone.9,10

Manage Exudate
  • Square white medical dressing for absorbing and retaining high levels of exudate.
    3M™ Kerramax Care™ Super-Absorbent Dressing

    Kerramax Care Dressing comprises a soft, non-woven material, horizontal wicking layer, super-absorbent core which together absorbs and retains high levels of exudate and potentially harmful bacteria11,12* and MMPs13* from the wound bed to facilitate healing and reduce the risk of maceration.14,15*


    *As demonstrated in vitro.

  • 3M™ Tegaderm™ High Performance Foam Dressings

    Designed to meet the challenges of low- to high-exudating wounds. These dressings integrate innovative layer technology to absorb and evaporate moisture to help maintain optimal wound healing environment.

  • 3M™ Tegaderm™ Silicone Foam Dressings

    Featuing 3M's innovative layer technology, 3M™ Tegaderm™ Silicone Foam Dressings provide longer wear time than the leading competitive silicone foam dressings16 while being gentle to skin.

  • A black and green pressure gauge that is part of the 3M™ Snap™ Therapy System.

    3M™ Snap™ Therapy System

    Snap Therapy System is a mechanically powered disposable NPWT system that's discreet, silent and lightweight - allowing patients to sleep with minimal interference and shower with the unit in place.

Support Granulation
  • A blue and white device with a digital screen that is part of the  3M™ ActiV.A.C™ Therapy System.

    3M™ ActiV.A.C.™ Therapy System

    ActiV.A.C. Therapy System is a portable NPWT device for the mobile patient with features that help maintain pressure at the wound site.

Support Granulation
  • A blue and white device with a digital screen that is part of the  3M™ ActiV.A.C™ Therapy System.

    3M™ ActiV.A.C.™ Therapy System

    ActiV.A.C. Therapy System is a portable NPWT device for the mobile patient with features that help maintain pressure at the wound site.

    Manage Exudate
  • Square white medical dressing for absorbing and retaining high levels of exudate.

    3M™ Kerramax Care™ Super-Absorbent Dressing

    Kerramax Care Dressing comprises a soft, non-woven material, horizontal wicking layer, super-absorbent core which together absorbs and retains high levels of exudate and potentially harmful bacteria11,12* and MMPs13* from the wound bed to facilitate healing and reduce the risk of maceration.14,15*


    *As demonstrated in vitro.

  • 3M™ Tegaderm™ High Performance Foam Dressings

    Designed to meet the challenges of low- to high-exudating wounds. These dressings integrate innovative layer technology to absorb and evaporate moisture to help maintain optimal wound healing environment.

  • 3M™ Tegaderm™ Silicone Foam Dressings

    Featuing 3M's innovative layer technology, 3M™ Tegaderm™ Silicone Foam Dressings provide longer wear time than the leading competitive silicone foam dressings16 while being gentle to skin.

  • A black and green pressure gauge that is part of the 3M™ Snap™ Therapy System.

    3M™ Snap™ Therapy System

    Snap Therapy System is a mechanically powered disposable NPWT system that's discreet, silent and lightweight - allowing patients to sleep with minimal interference and shower with the unit in place.

  • Support Granulation
  • A blue and white device with a digital screen that is part of the  3M™ ActiV.A.C™ Therapy System.

    3M™ ActiV.A.C.™ Therapy System

    ActiV.A.C. Therapy System is a portable NPWT device for the mobile patient with features that help maintain pressure at the wound site.


Step 3: Off-load

  • A doctor sitting in a waiting room, speaking with a patient.

    Care plan depends and differs from patient to patient.

    Determine appropriate plan of care/off-loading device, based on patient assessment, functional status, wound condition and frequency of reassessment. Follow facility policies and procedures. We can also help you determine what products best fit those policies and procedures, if necessary.

    Contact a Representative


Resources


References

  • Woodbury G. (2016, November). Foot Complications: Risking Limbs, Wasting Money. Wounds Canada, 14(3), 8-14.
  • Best Practice Recommendations for the Prevention and Management of Diabetic foot Ulcers. Wounds Canada, 2020. Available from: https://www.woundscanada.ca.
  • Diabetes Canada. Diabetes statistics in Canada. 2017. Available from: http://www.diabetes.ca/how-you-can-help/advocate/why-federal-leadership-is-essential/diabetes-statistics-in-canada
  • International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Wounds International, 2013. Available from: https://www.woundsinternational.com.
  • 3M Data on file, CLAIM-SHEET-US-05-201421_2
  • 3M Data on file, CLAIM-SHEET-US-05-262521_3
  • 3M Data on file, CLAIM-SHEET-US-05-201605_4
  • 3M Data on file, CLAIM-SHEET-US-05-147673
  • Cullen B, Watt P, Lundqvist C, et al. The role of oxidized regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action.Int J Biochem Cell Biol. 2002;34(12):1544-1556
  • Gibson M, Cullen B. Can natural materials be adapted to optimize their efficacy in wound care? Poster presented at: Society of Advanced Wound Healing (SAWC); 2014; Orlando, FL.
  • Cooper, R. An investigation into the ability of Kerramax Care™ and Kerrafoam™ to bind bacteria. Cardiff Metropolitan University. September 2013.
  • Singh G, Thomason H. Sequestration and retention of bacteria by superabsorbent dressings over time. KCI. CHC R1043 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
  • Singh G, Byrne C, Thomason H, McBain A. Investigating the microbial and metalloprotease sequestration properties of superabsorbent wound dressings. Sci Rep. 2022; 12 (1): 4747
  • Hughes, M. A large-scale evaluation of managing moderate and highly exuding wounds in the community. Wounds UK. 2017;13(3):78-85.
  • Jones J, Barraud J. An evaluation of Kerramax Care in the management of moderate to heavily exuding wounds. Br J Community Nurs. 2014 Mar; Suppl: S8, S50-53.
  • 10 cm x 10 cm and 15 cm x 15 cm (4 in x 4 in and 6 in x 6 in) dressings, based on In vivo studies EM-13977 and EM13978. Two times longer wear time than leading competitor silicone foam dressing when worn for 7 days (6.9 days for 3M™ Tegaderm™ Silicone Foam Dressing, 2.8 days for Mepilex(R) Border Foam Dressing).